24/10/2014 06:15:42 Free Membership Login

Cadence Pharmaceuticals News (NASDAQ:CADX)

DateTimeSource
Headline
03/19/20149:12AMBWMallinckrodt plc Completes $1.4 Billion Acquisition of Cadence Pharmaceuticals, Inc.
87.9% of Cadence’s outstanding shares were validly tendered, and subsequent merger has been completed Addition of high-growth OFIRMEV®, a differentiated pain product, will expand Mallinckrodt’s U.S. hospitals channel Mallinckrodt plc (NYSE:MNK), a leading global specialty pharmaceuticals company, today announced the... More...>>
03/13/20146:00PMZACKSFDA Approves Mallinckrodt's Xartemis XR - Analyst Blog
Mallinckrodt plc’s (MNK) extended-release oral formulation, Xartemis XR (oxycodone HCI and acetaminophen) gained U.S. Food and Drug Administration (FDA) approval for the management of acute pain in patients requiring opioid treatment and for whom alternative therapies are inadequate, ineffective or are not tolerated... More...>>
03/06/201411:50AMPRNUSStock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare
Stock Price Updates, Appointment, and Financial Results - Analyst Notes on Regeneron, DENTSPLY, AMAG, Cadence, and ArthroCare Editor Note: For more information about this release, please scroll to bottom. PR Newswire NEW YORK, March 6, 2014 NEW YORK, March 6, 2014 /PRNewswire/ -- Today, Analysts Review released its analysts... More...>>
02/28/20144:00PMPRNUSCadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results
Cadence Pharmaceuticals Reports Fourth Quarter and Full Year 2013 Financial Results PR Newswire SAN DIEGO, Feb. 28, 2014 SAN DIEGO, Feb. 28, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products... More...>>
02/19/20143:48PMPRNUSLifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision,...
Lifshitz & Miller Law Firm Announces Investigation of Cadence Pharmaceuticals, Inc., Chindex International, Inc., LCA-Vision, Inc., North Valley Bancorp and Texas Industries, Inc. PR Newswire NEW YORK, Feb. 19, 2014 NEW YORK, Feb. 19, 2014 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. Lifshitz & Miller announces... More...>>
02/17/20141:54PMBWSHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. in Connecti...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Company”) (Nasdaq: CADX) relating to the acquisition by Mallinckrodt plc (“MNK”). Click here to learn more about the investigation http://brodsky-smith.com/721-cadx-cadence-pharmaceuticals-inc-.html... More...>>
02/14/20143:50PMPRNUSCADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
CADENCE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout - Do you own shares of Cadence Pharmaceuticals, Inc. (NASDAQ GS: CADX)? - Did you purchase any of your shares prior to February 11, 2014? - Do you think the proposed buyout price is too low? - Do you want to discuss... More...>>
02/14/20141:06PMBWSHAREHOLDER DEADLINE: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc.
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Company”) (Nasdaq: CADX) relating to the acquisition by Mallinckrodt plc (“MNK”). Click here to learn more about the investigation http://brodsky-smith.com/721-cadx-cadence-pharmaceuticals-inc-.html... More...>>
02/13/20145:33PMBWINVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. & Its Board of Directors in Con...
Levi & Korsinsky is investigating the Board of Directors of Cadence Pharmaceuticals Inc. (“Cadence” or “the Company”) (NasdaqGS:CADX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Mallinckrodt plc. Click here to learn more about the action... More...>>
02/13/20143:24PMBWCADENCE INVESTOR ALERT: Faruqi & Faruqi, LLP is Investigating Cadence Pharmaceuticals, Inc. (CADX) in Relation to the Propose...
Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Cadence Pharmaceuticals, Inc. Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of... More...>>
02/12/20144:07PMPRNUSSHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX
SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cadence Pharmaceuticals, Inc. - CADX PR Newswire BALA CYNWYD, Pa., Feb. 12, 2014 BALA CYNWYD, Pa., Feb. 12, 2014 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board... More...>>
02/12/201411:26AMBWCadence Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe & Powers Taylor LLP Investigate Sale to Mallinc...
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Cadence Pharmaceuticals Inc. (“Cadence”) (NasdaqGS: CADX) related to the sale to Mallinckrodt plc for shareholders... More...>>
02/12/201410:31AMPRNUSRyan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc.
Ryan & Maniskas, LLP Announces Investigation of Cadence Pharmaceuticals Inc. PR Newswire WAYNE, Pa., Feb. 12, 2014 WAYNE, Pa., Feb. 12, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Cadence Pharmaceuticals Inc. ("Cadence" or the "Company") (NASDAQ:... More...>>
02/11/201410:25PMPRNUSHarwood Feffer LLP Announces Investigation of Cadence Pharmaceuticals, Inc.
Harwood Feffer LLP Announces Investigation of Cadence Pharmaceuticals, Inc. PR Newswire NEW YORK, Feb. 11, 2014 NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of Cadence Pharmaceuticals, Inc. ("Cadence" or the "Company") (NASDAQ:... More...>>
02/11/20144:48PMPRNUSAcquisition of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders' Best Interests
Acquisition of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc May Not Be in Shareholders' Best Interests PR Newswire SAN DIEGO, Feb. 11, 2014 SAN DIEGO, Feb. 11, 2014 /PRNewswire/ -- Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Cadence Pharmaceuticals, Inc. (NASDAQ:... More...>>
02/11/20144:30PMBWLaw Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Cadence Pharmaceuticals, Inc. Stockholders
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Cadence Pharmaceuticals, Inc. (“Cadence” or the “Company”) (NASDAQ: CADX) concerning the proposed acquisition of the Company by Mallinckrodt plc (“Mallinckrodt”) (NYSE: MNK). Under the terms of the definitive merger agreement... More...>>
02/11/20141:39PMPRNUSSHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Cadence ...
SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of Cadence Pharmaceuticals, Inc. - CADX PR Newswire NEW YORK, Feb. 11, 2014 NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cadence Pharmaceuticals... More...>>
02/11/20141:29PMPRNUSINVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In C...
INVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. and Its Board of Directors In Connection With the Sale of the Company to Mallinckrodt plc -- CADX PR Newswire NEW YORK, Feb. 11, 2014 NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Levi & Korsinsky is investigating the Board... More...>>
02/11/201412:17PMPRNUSCADENCE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cadence Pharmaceuticals, Inc. Over the Propose...
CADENCE SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Cadence Pharmaceuticals, Inc. Over the Proposed Sale of the Company to Mallinckrodt plc in a Cash Deal Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of... More...>>
02/11/201411:49AMBWINVESTOR ALERT: LEVI & KORSINSKY, LLP Announces Investigation of CADENCE PHARMACEUTICALS INC. & Its Board of Directors In Con...
Levi & Korsinsky is investigating the Board of Directors of Cadence Pharmaceuticals Inc. (“Cadence” or “the Company”) (NasdaqGS:CADX) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Mallinckrodt plc. Click here to learn more about the action... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq cadx141024 06:15